Evidence-Based Complementary and Alternative Medicine

Research Article

[Retracted] Study on the Predictive Value of Thromboelastography in Early Neurological Deterioration in Patients with Primary Acute Cerebral Infarction

Table 1

Comparison of baseline data at admission between the END and non-END groups (n, Mean ± SD).


Information		Non-END group (n = 109)	END group (n = 41)	t/χ ²

Gender (n, %)	Male	61 (55.96)	26 (63.41)	0.679	0.410
	Female	48 (44.04)	15 (36.59)

Age (years, Mean ± SD)		62.83 ± 7.67	64.95 ± 7.26	1.530	0.128
Onset of disease (h, Mean ± SD)		10.30 ± 2.18	11.17 ± 2.05	2.213	0.028

Hypertension (n, %)	Yes	42 (38.53)	19 (46.34)	2.569	0.109
	No	87 (79.82)	22(53.66)

CHD (n, %)	Yes	34 (31.19)	18 (43.90)	2.125	0.145
	No	75 (68.81)	23 (56.10)

DM (n, %)	Yes	23 (21.10)	17 (41.46)	6.317	0.012
	No	86 (78.90)	24 (58.54)

Hyperlipidemia (n, %)	Yes	26 (23.85)	6 (14.63)	1.509	0.219
	No	83 (76.15)	35 (85.37)

Smoking (n, %)	Yes	50 (45.87)	20 (48.78)	0.101	0.750
	No	59 (51.13)	21 (51.22)

Alcohol consumption (n, %)	Yes	33 (30.28)	8 (19.51)	1.738	0.187
	No	76 (69.72)	33 (80.49)

Baseline SBP (mmHg, Mean ± SD)		151.16 ± 23.38	153.27 ± 24.75	0.485	0.629

Baseline DBP (mmHg, Mean ± SD)		84.81 ± 12.15	85.46 ± 11.80	0.294	0.769

Baseline NHISS score (points, Mean ± SD)		6.53 ± 1.34	9.54 ± 1.87	10.940	0.001

PLT (×10⁹/L, Mean ± SD)		229.75 ± 21.30	230.27 ± 25.44	0.126	0.900

WBC (×10⁹/L, Mean ± SD)		7.19 ± 0.99	8.49 ± 1.23	6.693	0.001

TC (mmol/L, Mean ± SD)		4.43 ± 1.20	4.59 ± 1.21	0.726	0.469

TG (mmol/L, Mean ± SD)		1.80 ± 1.22	1.50 ± 0.79	1.462	0.146

HDL (mmol/L, Mean ± SD)		1.02 ± 0.30	1.08 ± 0.41	0.983	0.328

LDL (mmol/L, Mean ± SD)		2.81 ± 1.10	2.85 ± 1.13	0.197	0.844

CRP (mmol/L, Mean ± SD)		4.78 ± 1.12	6.52 ± 0.76	9.175	0.001

FBG (mmol/L, Mean ± SD)		7.22 ± 0.39	7.26 ± 0.81	0.407	0.685

Apolipoprotein A (g/L, Mean ± SD)		1.21 ± 0.23	1.22 ± 0.21	0.243	0.809

Apolipoprotein B (g/L, Mean ± SD)		0.81 ± 0.14	1.16 ± 0.40	7.963	0.001